Asker Healthcare Group
Current
Asker Healthcare Group builds and acquires leading companies within medical supplies, devices and equipment in Europe.
Investment year: 2019
Turnover 2023: SEK 13bn
- 3500 +
co-workers
- 14
markets
- 30 +
companies
Asker Healthcare Group builds and acquires leading companies within medical supplies, devices and equipment in Europe, supporting healthcare providers and patients to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain.
Every day, the services and products of Asker’s companies reach tens of thousands of nurses and healthcare professionals who meet millions of patients across Europe annually.
Asker’s history began in 1964 when medical supplies was added to the Tamroko Group product portfolio. Nalka Invest acquired Asker (then OneMed) in 2019 and since then the company has expanded its operation from 8 to 14 markets and established its position as one of Europe’s leading partners to the healthcare sector.
The company have evolved from having a Nordic focus within selected areas under the OneMed brand to become the Asker Healthcare Group with a pan-European operation including all aspects of healthcare products and services and many different leading brands.
Asker Healthcare Group is headquartered in Stockholm, Sweden and its portfolio consists of more than 30 companies, employing more than 3500 co-workers in Europe.
Investment year:2019
Turnover 2023:SEK 13bn
Industry:Healthcare
Nalkas ownership:70%
HQ:Stockholm, Sweden
Employees:2600
Website:www.asker.com
CEO:Johan Falk
Investment background
The European population is growing older and more are living longer with chronical diseases. This puts great pressure on the healthcare sector, with growing demands and expectations on care, as well as strained budgets.
Asker Healthcare Group has a strong business model with a distinct focus on patient welfare and enabling healthcare providers and prescribers to quickly and easily administer the right care, at a lower total cost and with improved care results.
Phazing out PVC
The companies in the Asker Healthcare Group introduce many initiatives and innovations to drive progress towards a more sustainable healthcare ecosystem, a commitment shared by Asker group and its customers.
As part of this work, Asker is constantly exploring alternative materials, both for products produced by group companies and products sourced from partners. One of the materials Asker is seeking to phase out is polyvinylchloride, commonly known as PVC.
PVC is a versatile material widely used in the medical industry. In 2020 it accounted for about 40% of all plastics-based medical devices used in hospitals. As a result of adverse impacts during disposal and low recycling rates, this common use of PVC is not optimal from an environmental point of view. PVC is also often used in combination with plasticizers which can leak out of products and have adverse effects on human health and the environment.
Asker is increasingly seeking to provide customers with alternatives to PVC and actively promote the benefits of substituting PVC products with a PVC-free alternative. For example, since 2021, Evercare offers the product series evercare® inLine, a product portfolio with a full range of PVC free infusion and injection sets.
